Single-dose isotope injection for both preoperative lymphoscintigraphy and intraoperative sentinel lymph node identification in melanoma patients

被引:50
作者
Thompson, JF
Niewind, P
Uren, RF
Bosch, CMJ
Howman-Giles, R
Vrouenraets, BC
机构
[1] Royal Prince Alfred Hosp, Sydney Melanoma Unit, Camperdown, NSW 2050, Australia
[2] Univ Sydney, Dept Surg, Sydney, NSW 2006, Australia
[3] Adv Nucl Med Serv, Sydney, NSW, Australia
关键词
gamma probe; lymphatic mapping; melanoma; sentinel lymph node;
D O I
10.1097/00008390-199712000-00009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
For patients with melanoma the `sentinel' lymph node biopsy technique, although simple in concept, has the potential to provide misleading information if great care is not taken to ensure accurate sentinel node (SN) identification. The method initially reported involved lymphatic mapping by injection of blue dye around the primary melanoma site. Preoperative lymphoscintigraphy was subsequently shown to improve both the speed and accuracy of SN identification. More recently, intraoperative use of a handheld gamma probe has been recommended, and it is likely that maximum reliability of SN biopsy will be achieved if all three manoeuvres are undertaken. As originally described, use of a gamma probe intraoperatively followed injection of tracer a short time before the surgical procedure. We report a simpler method of confirming SN identity with a gamma probe, using residual activity in the node following lymphoscintigraphy the previous day. In 21 patients close concordance with preoperative lymphoscintigram results and intraoperative findings after blue dye injection confirmed the reliability of the technique. Avoiding the need for repeat isotope administration on the day of surgery simplifies logistics, reduces costs, minimizes inconvenience and radiation dose for patients, and eliminates potential health and safety problems for operating theatre staff.
引用
收藏
页码:500 / 506
页数:7
相关论文
共 15 条
[1]   Intraoperative radiolymphoscintigraphy improves sentinel lymph node identification for patients with melanoma [J].
Albertini, JJ ;
Cruse, CW ;
Rapaport, D ;
Wells, K ;
Ross, M ;
DeConti, R ;
Berman, CG ;
Jared, K ;
Messina, J ;
Lyman, G ;
Glass, F ;
Fenske, N ;
Reintgen, DS .
ANNALS OF SURGERY, 1996, 223 (02) :217-224
[2]   GAMMA-PROBE-GUIDED LYMPH-NODE LOCALIZATION IN MALIGNANT-MELANOMA [J].
ALEX, JC ;
WEAVER, DL ;
FAIRBANK, JT ;
RANKIN, BS ;
KRAG, DN .
SURGICAL ONCOLOGY-OXFORD, 1993, 2 (05) :303-308
[3]   PARTICLE SIZING AND BIOKINETICS OF INTERSTITIAL LYMPHOSCINTIGRAPHIC AGENTS [J].
BERGQVIST, L ;
STRAND, SE ;
PERSSON, BRR .
SEMINARS IN NUCLEAR MEDICINE, 1983, 13 (01) :9-19
[4]  
ESSNER R, 1994, P 47 CANC S
[5]  
KAPTEIJN BAE, 1995, EUR J NUCL MED, V22, P753
[6]  
MCCARTHY WH, 1995, ARCH SURG-CHICAGO, V130, P659
[7]  
MORTON DL, 1992, ARCH SURG-CHICAGO, V127, P392
[8]   Rates of flow of technetium 99m-labeled human serum albumin from peripheral injection sites to sentinel lymph nodes [J].
Nathanson, SD ;
Nelson, L ;
Karvelis, KC .
ANNALS OF SURGICAL ONCOLOGY, 1996, 3 (04) :329-335
[9]  
NIEWEG OE, 1994, EUR SOC SURG ONC HEI
[10]   REDEFINITION OF CUTANEOUS LYMPHATIC DRAINAGE WITH THE USE OF LYMPHOSCINTIGRAPHY FOR MALIGNANT-MELANOMA [J].
NORMAN, J ;
CRUSE, CW ;
ESPINOSA, C ;
COX, C ;
BERMAN, C ;
CLARK, R ;
SABA, H ;
WELLS, K ;
REINTGEN, D .
AMERICAN JOURNAL OF SURGERY, 1991, 162 (05) :432-437